A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo – A substudy for IBIS I Breast Cancer Prevention Trial
- Resource Type
- Article
- Source
- In
European Journal of Cancer January 2013 49(1):45-51 - Subject
- Language
- ISSN
- 0959-8049